2020
Safety of oral naltrexone in HIV-positive men who have sex with men and transgender women with alcohol use disorder and initiating antiretroviral therapy
Gonzales P, Grieco A, White E, Ding R, Ignacio RB, Pinto-Santini D, Lama JR, Altice FL, Duerr A. Safety of oral naltrexone in HIV-positive men who have sex with men and transgender women with alcohol use disorder and initiating antiretroviral therapy. PLOS ONE 2020, 15: e0228433. PMID: 32134956, PMCID: PMC7058313, DOI: 10.1371/journal.pone.0228433.Peer-Reviewed Original ResearchConceptsAlcohol use disorderAntiretroviral therapyClinical adverse eventsAdverse eventsTransgender womenUse disordersDouble-blind randomized placebo-controlled trialMSM/transgender womenRandomized placebo-controlled trialART-naïve participantsPossibility of hepatotoxicityPlacebo-controlled trialSerious adverse eventsHIV-positive menMedication-assisted therapyProportion of subjectsAdverse event dataMultiple new medicationsOral naltrexoneStudy medicationTransaminase elevationPlacebo armNTX treatmentTreatment armsNew medications
2015
Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan
Azbel L, Wickersham JA, Wegman MP, Polonsky M, Suleymanov M, Ismayilov R, Dvoryak S, Rotberga S, Altice FL. Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan. Drug And Alcohol Dependence 2015, 151: 68-75. PMID: 25861943, PMCID: PMC4447560, DOI: 10.1016/j.drugalcdep.2015.02.034.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyDrug injectionInfectious diseasesPrevalence of HCVSignificant independent correlatesLow HIV prevalenceHigh-endemic countriesHigh diagnostic rateEvidence-based addiction treatmentSubstance use disordersHealth assessment surveyHCV epidemicHepatitis BHCV diagnosisHIV statusHIV prevalenceART coverageHIV treatmentIndependent correlatesNew medicationsHIV epidemicHeterosexual riskHealth SurveyEndemic countriesHIV